Day: May 18, 2020

U.S. FDA Gives Nod To Bristol-Myers Combo Therapy For Lung Cancer

Lung Cancer Therapy
Non-small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases. Lung cancer patients in advanced stages of the disease have received a new [...]